Clinical Trials Logo

Clinical Trial Summary

Diarrheal disease is one of the major causes of morbidity and mortality in children under five. Disease is treated symptomatically with oral rehydration (ORS) as a basic measure. In children with severe zinc deficiency, diarrhea is common and responds quickly to zinc supplementation. Zinc supplementation may also helpful in diarrheal children without zinc deficiency. Effectiveness of zinc was proven in developing countries but was not in Europe. Objective of our study is to assess whether zinc supplementation given with probiotics and ORS is effective in acute diarrhea in children in Poland.


Clinical Trial Description

A double-blind, placebo controlled trial

- We are going to enroll 256 patients (aged > 1 months to 36 months) with acute watery diarrhea defined as 3 d or more watery stools per day lasting not less than 1 day and not longer than 5 days.

Exclusion criteria:

severe dehydration (> 10%) Coexisting severe infection (E.g. Sepsis, pneumonia, meningitis) Immune deficiency Chronic digestive tract disease (e.g. celiac diseases, food allergy) Therapy with Antibiotics

Patients will be randomly assigned to 2 groups to receive: (a) zinc sulfate 10-20 mg/day for 10 days plus probiotics for 5 days (b) placebo for 10 days plus probiotics for 5 days. Patients will be observed in ambulatory or in the hospital (if necessary) and followed up for 15 days.

Randomization 1:1 ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01140074
Study type Interventional
Source University Hospital No 1 Wroclaw
Contact Leszek Szenborn, Prof
Phone ++48717703151
Email szenborn@zak.am.wroc.pl
Status Not yet recruiting
Phase Phase 2
Start date July 2010
Completion date June 2012

See also
  Status Clinical Trial Phase
Completed NCT00325247 - Efficacy of Zinc Therapy in Acute Diarrhoea in Young Children Phase 3
Completed NCT06179589 - VS002A in the Treatment of Acute Watery Diarrhea in Infants and Young Children N/A